Cancellation of state registration. Zetamax retard

August 30, 2017
Active substances:
Trade names:
ICD-10:
X.J00-J06.J01    Acute Sinusitis
X.J10-J18.J15    Bacterial pneumonia, not elsewhere classified
X.J10-J18.J16.0    Pneumonia caused by chlamydia
X.J10-J18.J15.7    Pneumonia caused by Mycoplasma pneumoniae
Zetamax retard, azithromycin, acute bacterial sinusitis, pneumonia

The Ministry of Health of the Russian Federation in accordance with Article 32 of the Federal Law of 12.04.2010 No. 61-FZ "On the circulation of medicines" decided to cancelstate registration and exclusion from the state register of medicinal products for the medical use of the medicinal product (registration certificate LS-001823 dated September 28, 2011 issued by Pfizer Pharmaceuticals ElEles, Puerto Rico (USA)):

Zetamax retard (trade name of the medicinal product)

Azithromycin (international non-patented or batch or chemical name)

powder for the preparation of a suspension of prolonged action for oral administration, 2 g (dosage form, dosage)

Pfizer Pharmaceuticals ElEles, Puerto Rico (USA) KM 1.9 Road 689, Vega Baja, PR 00693, Puerto-Rico (USA) (name and address of the location of the manufacturer of the medicinal product)

on the basis of filing an application by an authorized legal entity LLC Pfizer for the abolition of state registration of a medicinal product.